Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency
- Adeli, M
- Walter, JE
- Notarangelo, LD
- Hill, HR
- Bousfiha, AA
- Villartay, JP
- Moshous, D
- Neven, B
- Pashchenko, O
- Boztug, K
- Hoeger, B
- Bredius, R
- Kiykim, A
- Baris, S
- Karakoc-Aydiner, E
- Ozen, A
- Henrickson, SE
- Fadugba, O
- Holland, SM
- Kriván, G
- Goda, V
- Westermann-Clark, E
- Miano, M
- Chandrakasan, S
- Stepensky, P
- Nicholas, SK
- Hernandez, JD
- Butte, MJ
- Wolska-Kuśnierz, B
- Bonfim, C
- Hazen, MM
- Henderson, LA
- Wolf, HM
- Eibl, MM
- Geier, CB
- Gelfand, EW
- Dutmer, CM
- Pai, SY
- Dilley, MA
- Al-Saad, KK
- Karakukcu, MUSA
- Patiroglu, TÜRKAN
- Unal, EKREM
- Dbaibo, G
- Fischer, BM
- Pinero, G
- Parikh, S
- Sleasman, JW
- Tzanoudaki, M
- Lycopoulou, L
- Kanariou, MG
- Geha, RS
- Di, Matteo
- Locatelli, F
- Bertaina, A
- Palma, P
- Cancrini, C
- Puck, JM
- Abolhassani, H
- Aghamohammadi, A
- Ferguson, PJ
- Reiff, A
- Booth, C
- Buchbinder, D
- Costa-Carvalho, BT
- Joshi, AY
- Abraham, RS
- Al-Herz, W
- Schuetz, C
- Bleesing, JJH
- Chen, K
- De, Ravin
- Ujhazi, B
- Foldvari, Z
- Farmer, JR
DOIAbstract
BACKGROUND: Although autoimmunity and hyperinflammation secondary to recombination activating gene (RAG) deficiency have been associated with delayed diagnosis and even death, our current understanding is limited primarily to small case series
Add to ORKG